Not Yet Recruiting EARLY_PHASE1 INTERVENTIONAL 2-arm
NCT07291375
Role of Amlodipine in Reduction of CIN
The Effect of Low Dose Oral Amlodipine in Renal Protection From Contrast Induced Nephropathy in Diabetic Patients in Intensive Care Unit
Sponsor: Minia University
Conditions
Contrast-induced Nephropathy
Interventions
Calcium channel blocker Hydration
Updated 1 time since 2026 Last updated: Dec 5, 2025 Started: Dec 20, 2025 Primary completion: Jun 1, 2026 Completion: Jul 1, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A EARLY_PHASE1 clinical study on Contrast-induced Nephropathy, this trial is actively recruiting participants. The trial is conducted by Minia University and has accumulated 1 data snapshot since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Not Yet Recruiting — EARLY_PHASE1
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Minia University
Data source: Minia University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.